{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:27:05Z","timestamp":1790638025825,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,4,2]],"date-time":"2013-04-02T00:00:00Z","timestamp":1364860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Glycoconj J"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s10719-013-9473-y","type":"journal-article","created":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T05:05:50Z","timestamp":1364792750000},"page":"687-699","source":"Crossref","is-referenced-by-count":22,"title":["A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells"],"prefix":"10.1007","volume":"30","author":[{"given":"Ana Victoria","family":"Casades\u00fas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuniel","family":"Fern\u00e1ndez-Marrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Clavell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Alberto","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tays","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"L\u00f3pez-Requena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,2]]},"reference":[{"issue":"1","key":"9473_CR1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00062752-200301000-00004","volume":"10","author":"S Hakomori","year":"2003","unstructured":"Hakomori, S.: Structure, organization, and function of glycosphingolipids in membrane. Curr. Opin. Hematol. 10(1), 16\u201324 (2003)","journal-title":"Curr. Opin. Hematol."},{"issue":"5","key":"9473_CR2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.sbi.2009.06.001","volume":"19","author":"PH Lopez","year":"2009","unstructured":"Lopez, P.H., Schnaar, R.L.: Gangliosides in cell recognition and membrane protein regulation. Curr. Opin. Struct. Biol. 19(5), 549\u2013557 (2009). doi: 10.1016\/j.sbi.2009.06.001","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"1","key":"9473_CR3","doi-asserted-by":"crossref","first-page":"1R","DOI":"10.1093\/glycob\/cwl052","volume":"17","author":"S Sonnino","year":"2007","unstructured":"Sonnino, S., Mauri, L., Chigorno, V., Prinetti, A.: Gangliosides as components of lipid membrane domains. Glycobiology 17(1), 1R\u201313R (2007). doi: 10.1093\/glycob\/cwl052","journal-title":"Glycobiology"},{"key":"9473_CR4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fphys.2010.00153","volume":"1","author":"S Sonnino","year":"2010","unstructured":"Sonnino, S., Prinetti, A.: Lipids and membrane lateral organization. Front. Physiol. 1, 153 (2010). doi: 10.3389\/fphys.2010.00153","journal-title":"Front. Physiol."},{"issue":"8","key":"9473_CR5","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.chemphyslip.2011.09.005","volume":"164","author":"L Cantu","year":"2011","unstructured":"Cantu, L., Del Favero, E., Sonnino, S., Prinetti, A.: Gangliosides and the multiscale modulation of membrane structure. Chem. Phys. Lipids 164(8), 796\u2013810 (2011). doi: 10.1016\/j.chemphyslip.2011.09.005","journal-title":"Chem. Phys. Lipids"},{"issue":"23","key":"9473_CR6","first-page":"5309","volume":"56","author":"S Hakomori","year":"1996","unstructured":"Hakomori, S.: Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 56(23), 5309\u20135318 (1996)","journal-title":"Cancer Res."},{"key":"9473_CR7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/978-1-4419-7877-6_34","volume":"705","author":"A Prinetti","year":"2011","unstructured":"Prinetti, A., Prioni, S., Loberto, N., Aureli, M., Nocco, V., Illuzzi, G., Mauri, L., Valsecchi, M., Chigorno, V., Sonnino, S.: Aberrant glycosphingolipid expression and membrane organization in tumor cells: consequences on tumor-host interactions. Adv. Exp. Med. Biol. 705, 643\u2013667 (2011). doi: 10.1007\/978-1-4419-7877-6_34","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"9473_CR8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2249.2011.04516.x","volume":"167","author":"LG Durrant","year":"2012","unstructured":"Durrant, L.G., Noble, P., Spendlove, I.: Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy. Clin. Exp. Immunol. 167(2), 206\u2013215 (2012). doi: 10.1111\/j.1365-2249.2011.04516.x","journal-title":"Clin. Exp. Immunol."},{"issue":"8","key":"9473_CR9","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2217\/fon.12.88","volume":"8","author":"C Rabu","year":"2012","unstructured":"Rabu, C., McIntosh, R., Jurasova, Z., Durrant, L.: Glycans as targets for therapeutic antitumor antibodies. Future Oncol. 8(8), 943\u2013960 (2012). doi: 10.2217\/fon.12.88","journal-title":"Future Oncol."},{"issue":"8","key":"9473_CR10","first-page":"3796","volume":"45","author":"H Higashi","year":"1985","unstructured":"Higashi, H., Hirabayashi, Y., Fukui, Y., Naiki, M., Matsumoto, M., Ueda, S., Kato, S.: Characterization of N-glycolylneuraminic acid-containing gangliosides as tumor-associated Hanganutziu-Deicher antigen in human colon cancer. Cancer Res. 45(8), 3796\u20133802 (1985)","journal-title":"Cancer Res."},{"issue":"22","key":"9473_CR11","first-page":"5165","volume":"56","author":"G Marquina","year":"1996","unstructured":"Marquina, G., Waki, H., Fernandez, L.E., Kon, K., Carr, A., Valiente, O., Perez, R., Ando, S.: Gangliosides expressed in human breast cancer. Cancer Res. 56(22), 5165\u20135171 (1996)","journal-title":"Cancer Res."},{"issue":"3","key":"9473_CR12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10719-008-9183-z","volume":"26","author":"A Varki","year":"2009","unstructured":"Varki, A.: Multiple changes in sialic acid biology during human evolution. Glycoconj. J. 26(3), 231\u2013245 (2009). doi: 10.1007\/s10719-008-9183-z","journal-title":"Glycoconj. J."},{"issue":"25","key":"9473_CR13","doi-asserted-by":"crossref","first-page":"15866","DOI":"10.1074\/jbc.273.25.15866","volume":"273","author":"A Irie","year":"1998","unstructured":"Irie, A., Koyama, S., Kozutsumi, Y., Kawasaki, T., Suzuki, A.: The molecular basis for the absence of N-glycolylneuraminic acid in humans. J. Biol. Chem. 273(25), 15866\u201315871 (1998)","journal-title":"J. Biol. Chem."},{"issue":"21","key":"9473_CR14","doi-asserted-by":"crossref","first-page":"12045","DOI":"10.1073\/pnas.2131556100","volume":"100","author":"P Tangvoranuntakul","year":"2003","unstructured":"Tangvoranuntakul, P., Gagneux, P., Diaz, S., Bardor, M., Varki, N., Varki, A., Muchmore, E.: Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc. Natl. Acad. Sci. U. S. A. 100(21), 12045\u201312050 (2003). doi: 10.1073\/pnas.2131556100","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"9473_CR15","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1074\/jbc.M412040200","volume":"280","author":"M Bardor","year":"2005","unstructured":"Bardor, M., Nguyen, D.H., Diaz, S., Varki, A.: Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells. J. Biol. Chem. 280(6), 4228\u20134237 (2005). doi: 10.1074\/jbc.M412040200","journal-title":"J. Biol. Chem."},{"issue":"34","key":"9473_CR16","doi-asserted-by":"crossref","first-page":"28852","DOI":"10.1074\/jbc.M112.364182","volume":"287","author":"K Banda","year":"2012","unstructured":"Banda, K., Gregg, C.J., Chow, R., Varki, N.M., Varki, A.: Metabolism of vertebrate amino sugars with N-glycolyl groups: mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen N-glycolylneuraminic acid. J. Biol. Chem. 287(34), 28852\u201328864 (2012). doi: 10.1074\/jbc.M112.364182","journal-title":"J. Biol. Chem."},{"issue":"12","key":"9473_CR17","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1128\/MCB.00379-07","volume":"27","author":"M Hedlund","year":"2007","unstructured":"Hedlund, M., Tangvoranuntakul, P., Takematsu, H., Long, J.M., Housley, G.D., Kozutsumi, Y., Suzuki, A., Wynshaw-Boris, A., Ryan, A.F., Gallo, R.L., Varki, N., Varki, A.: N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution. Mol. Cell. Biol. 27(12), 4340\u20134346 (2007). doi: 10.1128\/MCB.00379-07","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"9473_CR18","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1158\/0008-5472.CAN-05-2615","volume":"66","author":"J Yin","year":"2006","unstructured":"Yin, J., Hashimoto, A., Izawa, M., Miyazaki, K., Chen, G.Y., Takematsu, H., Kozutsumi, Y., Suzuki, A., Furuhata, K., Cheng, F.L., Lin, C.H., Sato, C., Kitajima, K., Kannagi, R.: Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells. Cancer Res. 66(6), 2937\u20132945 (2006). doi: 10.1158\/0008-5472.CAN-05-2615","journal-title":"Cancer Res."},{"issue":"9","key":"9473_CR19","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.febslet.2009.11.019","volume":"584","author":"J Yin","year":"2010","unstructured":"Yin, J., Miyazaki, K., Shaner, R.L., Merrill Jr., A.H., Kannagi, R.: Altered sphingolipid metabolism induced by tumor hypoxia\u2014new vistas in glycolipid tumor markers. FEBS Lett. 584(9), 1872\u20131878 (2010). doi: 10.1016\/j.febslet.2009.11.019","journal-title":"FEBS Lett."},{"issue":"3","key":"9473_CR20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/02724570050109639","volume":"19","author":"A Carr","year":"2000","unstructured":"Carr, A., Mullet, A., Mazorra, Z., Vazquez, A.M., Alfonso, M., Mesa, C., Rengifo, E., Perez, R., Fernandez, L.E.: A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors. Hybridoma 19(3), 241\u2013247 (2000). doi: 10.1089\/02724570050109639","journal-title":"Hybridoma"},{"issue":"2","key":"9473_CR21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10549-005-9064-0","volume":"96","author":"JP Oliva","year":"2006","unstructured":"Oliva, J.P., Valdes, Z., Casaco, A., Pimentel, G., Gonzalez, J., Alvarez, I., Osorio, M., Velazco, M., Figueroa, M., Ortiz, R., Escobar, X., Orozco, M., Cruz, J., Franco, S., Diaz, M., Roque, L., Carr, A., Vazquez, A.M., Mateos, C., Rubio, M.C., Perez, R., Fernandez, L.E.: Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with (99\u00a0m)Tc. Breast Cancer Res. Treat. 96(2), 115\u2013121 (2006). doi: 10.1007\/s10549-005-9064-0","journal-title":"Breast Cancer Res. Treat."},{"key":"9473_CR22","doi-asserted-by":"crossref","unstructured":"Fernandez-Marrero, Y., Roque-Navarro, L., Hernandez, T., Dorvignit, D., Molina-Perez, M., Gonzalez, A., Sosa, K., Lopez-Requena, A., Perez, R., Mateo de Acosta, C.: A cytotoxic humanized anti-ganglioside antibody produced in a murine cell line defective of N-glycolylated-glycoconjugates. Immunobiology (2011). doi: 10.1016\/j.imbio.2011.07.004","DOI":"10.1016\/j.imbio.2011.07.004"},{"issue":"4","key":"9473_CR23","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4161\/cbt.7.4.5476","volume":"7","author":"M Osorio","year":"2008","unstructured":"Osorio, M., Gracia, E., Rodriguez, E., Saurez, G., Arango Mdel, C., Noris, E., Torriella, A., Joan, A., Gomez, E., Anasagasti, L., Gonzalez, J.L., Melgares Mde, L., Torres, I., Gonzalez, J., Alonso, D., Rengifo, E., Carr, A., Perez, R., Fernandez, L.E.: Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a Phase Ib\/IIa study. Cancer Biol. Ther. 7(4), 488\u2013495 (2008)","journal-title":"Cancer Biol. Ther."},{"key":"9473_CR24","doi-asserted-by":"crossref","first-page":"848909","DOI":"10.5402\/2011\/848909","volume":"2011","author":"R Blanco","year":"2011","unstructured":"Blanco, R., Rengifo, E., Rengifo, C.E., Cedeno, M., Frometa, M., Carr, A.: Immunohistochemical reactivity of the 14F7 monoclonal antibody raised against N-glycolyl GM3 ganglioside in some benign and malignant skin neoplasms. ISRN Dermatol. 2011, 848909 (2011). doi: 10.5402\/2011\/848909","journal-title":"ISRN Dermatol."},{"issue":"8","key":"9473_CR25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1601-0825.2012.01939.x","volume":"18","author":"Y Zhong","year":"2012","unstructured":"Zhong, Y., Wu, Y., Li, C., Tang, J., Wang, X., Ren, G., Carr, A., Perez, R., Guo, W.: N-Glycolyl GM3 ganglioside immunoexpression in oral mucosal melanomas of Chinese. Oral Dis. 18(8), 741\u2013747 (2012). doi: 10.1111\/j.1601-0825.2012.01939.x","journal-title":"Oral Dis."},{"key":"9473_CR26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1471-2407-9-180","volume":"9","author":"H Cruijsen van","year":"2009","unstructured":"van Cruijsen, H., Ruiz, M.G., van der Valk, P., de Gruijl, T.D., Giaccone, G.: Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer. BMC Cancer 9, 180 (2009). doi: 10.1186\/1471-2407-9-180","journal-title":"BMC Cancer"},{"key":"9473_CR27","first-page":"235418","volume":"2012","author":"R Blanco","year":"2012","unstructured":"Blanco, R., Rengifo, C.E., Cedeno, M., Frometa, M., Rengifo, E., Carr, A.: Immunoreactivity of the 14F7 mab (raised against N-glycolyl GM3 ganglioside) as a positive prognostic factor in non-small-cell lung cancer. Patholog. Res. Int. 2012, 235418 (2012). doi: 10.1155\/2012\/235418","journal-title":"Patholog. Res. Int."},{"issue":"1","key":"9473_CR28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/cas.12027","volume":"104","author":"N Hayashi","year":"2013","unstructured":"Hayashi, N., Chiba, H., Kuronuma, K., Go, S., Hasegawa, Y., Takahashi, M., Gasa, S., Watanabe, A., Hasegawa, T., Kuroki, Y., Inokuchi, J., Takahashi, H.: Detection of N-glycolyated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody. Cancer Sci. 104(1), 43\u201347 (2013). doi: 10.1111\/cas.12027","journal-title":"Cancer Sci."},{"issue":"1","key":"9473_CR29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2350\/08-10-0544.1","volume":"13","author":"AM Scursoni","year":"2010","unstructured":"Scursoni, A.M., Galluzzo, L., Camarero, S., Pozzo, N., Gabri, M.R., de Acosta, C.M., Vazquez, A.M., Alonso, D.F., de Davila, M.T.: Detection and characterization of N-glycolyated gangliosides in Wilms tumor by immunohistochemistry. Pediatr. Dev. Pathol. 13(1), 18\u201323 (2010). doi: 10.2350\/08-10-0544.1","journal-title":"Pediatr. Dev. Pathol."},{"key":"9473_CR30","doi-asserted-by":"crossref","first-page":"245181","DOI":"10.1155\/2011\/245181","volume":"2011","author":"AM Scursoni","year":"2011","unstructured":"Scursoni, A.M., Galluzzo, L., Camarero, S., Lopez, J., Lubieniecki, F., Sampor, C., Segatori, V.I., Gabri, M.R., Alonso, D.F., Chantada, G., de Davila, M.T.: Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer. Clin. Dev. Immunol. 2011, 245181 (2011). doi: 10.1155\/2011\/245181","journal-title":"Clin. Dev. Immunol."},{"key":"9473_CR31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fonc.2012.00195","volume":"2","author":"C Sampor","year":"2012","unstructured":"Sampor, C., Guthmann, M.D., Scursoni, A., Cacciavillano, W., Torbidoni, A., Galluzzo, L., Camarero, S., Lopez, J., de Davila, M.T., Fainboim, L., Chantada, G.L.: Immune response to racotumomab in a child with relapsed neuroblastoma. Front. Oncol. 2, 195 (2012). doi: 10.3389\/fonc.2012.00195","journal-title":"Front. Oncol."},{"key":"9473_CR32","doi-asserted-by":"crossref","first-page":"602417","DOI":"10.1155\/2013\/602417","volume":"2013","author":"R Blanco","year":"2013","unstructured":"Blanco, R., Quintana, Y., Blanco, D., Cede\u00f1o, M., Rengifo, C.E., Fr\u00f3meta, M., R\u00edos, M., Rengifo, E., Carr, A.: Tissue reactivity of the 14F7 mab raised against N-Glycolyl GM3 ganglioside in tumors of neuroectodermal, mesodermal, and epithelial origin. J. Biomarkers 2013, 602417 (2013). doi: 10.1155\/2013\/602417","journal-title":"J. Biomarkers"},{"key":"9473_CR33","doi-asserted-by":"crossref","first-page":"645641","DOI":"10.5402\/2011\/645641","volume":"2011","author":"R Blanco","year":"2011","unstructured":"Blanco, R., Rengifo, E., Cedeno, M., Rengifo, C.E., Alonso, D.F., Carr, A.: Immunoreactivity of the 14F7 mab raised against N-glycolyl GM3 ganglioside in epithelial malignant tumors from digestive system. ISRN Gastroenterol. 2011, 645641 (2011). doi: 10.5402\/2011\/645641","journal-title":"ISRN Gastroenterol."},{"key":"9473_CR34","doi-asserted-by":"crossref","first-page":"953803","DOI":"10.5402\/2011\/953803","volume":"2011","author":"R Blanco","year":"2011","unstructured":"Blanco, R., Cede\u00f1o, M., Escobar, X., Blanco, D., Rengifo, C.E., Fr\u00f3meta, M., Alvarez, R.I., Rengifo, E., Carr, A.: Immunorecognition of the 14F7 mab raised against N-glycolyl GM3 ganglioside in some normal and malignant tissues from genitourinary system. ISRN Pathology 2011, 953803 (2011). doi: 10.5402\/2011\/953803","journal-title":"ISRN Pathology"},{"key":"9473_CR35","doi-asserted-by":"crossref","first-page":"814397","DOI":"10.1155\/2010\/814397","volume":"2010","author":"LE Fernandez","year":"2010","unstructured":"Fernandez, L.E., Gabri, M.R., Guthmann, M.D., Gomez, R.E., Gold, S., Fainboim, L., Gomez, D.E., Alonso, D.F.: NGcGM3 ganglioside: a privileged target for cancer vaccines. Clin. Dev. Immunol. 2010, 814397 (2010). doi: 10.1155\/2010\/814397","journal-title":"Clin. Dev. Immunol."},{"issue":"6","key":"9473_CR36","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1200\/JCO.2003.02.124","volume":"21","author":"A Carr","year":"2003","unstructured":"Carr, A., Rodriguez, E., Arango Mdel, C., Camacho, R., Osorio, M., Gabri, M., Carrillo, G., Valdes, Z., Bebelagua, Y., Perez, R., Fernandez, L.E.: Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine. J. Clin. Oncol. 21(6), 1015\u20131021 (2003)","journal-title":"J. Clin. Oncol."},{"key":"9473_CR37","unstructured":"Mulens, V., de la Torre, A., Marinello, P., Rodriguez, R., Cardoso, J., Diaz, R., O\u2019Farrill, M., Macias, A., Viada, C., Saurez, G., Carr, A., Crombet, T., Mazorra, Z., Perez, R., Fernandez, L.E.: Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: results from a controlled study in metastatic breast cancer patients. Hum. Vaccin. 6(9) (2010). doi: 10.4161.hv.6.9.12571"},{"key":"9473_CR38","doi-asserted-by":"crossref","unstructured":"Perez, K., Osorio, M., Hernandez, J., Carr, A., Fernandez, L.E.: NGcGM3\/VSSP vaccine as treatment for melanoma patients. Hum. Vaccin. Immunother. 9(6) (2013)","DOI":"10.4161\/hv.24115"},{"key":"9473_CR39","first-page":"150","volume":"2","author":"AM Vazquez","year":"2012","unstructured":"Vazquez, A.M., Hernandez, A.M., Macias, A., Montero, E., Gomez, D.E., Alonso, D.F., Gabri, M.R., Gomez, R.E.: Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides\u2014preclinical and clinical data. Front. Oncol. 2, 150 (2012). doi: 10.3389\/fonc.2012.00150","journal-title":"Front. Oncol."},{"issue":"6","key":"9473_CR40","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/hyb.1995.14.551","volume":"14","author":"AM Vazquez","year":"1995","unstructured":"Vazquez, A.M., Alfonso, M., Lanne, B., Karlsson, K.A., Carr, A., Barroso, O., Fernandez, L.E., Rengifo, E., Lanio, M.E., Alvarez, C., et al.: Generation of a murine monoclonal antibody specific for N-glycolylneuraminic acid-containing gangliosides that also recognizes sulfated glycolipids. Hybridoma 14(6), 551\u2013556 (1995)","journal-title":"Hybridoma"},{"issue":"6","key":"9473_CR41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/153685902321043990","volume":"21","author":"A Carr","year":"2002","unstructured":"Carr, A., Mesa, C., del Carmen Arango, M., Vazquez, A.M., Fernandez, L.E.: In vivo and in vitro anti-tumor effect of 14F7 monoclonal antibody. Hybrid Hybridomics 21(6), 463\u2013468 (2002). doi: 10.1089\/153685902321043990","journal-title":"Hybrid Hybridomics"},{"issue":"7","key":"9473_CR42","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1158\/1535-7163.MCT-08-0222","volume":"7","author":"L Roque-Navarro","year":"2008","unstructured":"Roque-Navarro, L., Chakrabandhu, K., de Leon, J., Rodriguez, S., Toledo, C., Carr, A., de Acosta, C.M., Hueber, A.O., Perez, R.: Anti-ganglioside antibody-induced tumor cell death by loss of membrane integrity. Mol. Cancer Ther. 7(7), 2033\u20132041 (2008). doi: 10.1158\/1535-7163.MCT-08-0222","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"9473_CR43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/027245700750053959","volume":"19","author":"C Mateo","year":"2000","unstructured":"Mateo, C., Lombardero, J., Moreno, E., Morales, A., Bombino, G., Coloma, J., Wims, L., Morrison, S.L., Perez, R.: Removal of amphipathic epitopes from genetically engineered antibodies: production of modified immunoglobulins with reduced immunogenicity. Hybridoma 19(6), 463\u2013471 (2000). doi: 10.1089\/027245700750053959","journal-title":"Hybridoma"},{"issue":"6","key":"9473_CR44","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4161\/mabs.3.6.17770","volume":"3","author":"Y Fernandez-Marrero","year":"2011","unstructured":"Fernandez-Marrero, Y., Lopez-Requena, A.: Lonely killers: Effector cell- and complement-independent non-proapoptotic cytotoxic antibodies inducing membrane lesions. MAbs 3(6), 528\u2013534 (2011). doi: 10.4161\/mabs.3.6.17770","journal-title":"MAbs"},{"issue":"8","key":"9473_CR45","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.molimm.2011.01.008","volume":"48","author":"Y Fernandez-Marrero","year":"2011","unstructured":"Fernandez-Marrero, Y., Hernandez, T., Roque-Navarro, L., Talavera, A., Moreno, E., Grinan, T., Vazquez, A.M., de Acosta, C.M., Perez, R., Lopez-Requena, A.: Switching on cytotoxicity by a single mutation at the heavy chain variable region of an anti-ganglioside antibody. Mol. Immunol. 48(8), 1059\u20131067 (2011). doi: 10.1016\/j.molimm.2011.01.008","journal-title":"Mol. Immunol."},{"issue":"2","key":"9473_CR46","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1021\/cb3003754","volume":"8","author":"G Rojas","year":"2013","unstructured":"Rojas, G., Pupo, A., Gomez, S., Krengel, U., Moreno, E.: Engineering the binding site of an antibody against N-glycolyl GM3: from functional mapping to novel anti-ganglioside specificities. ACS Chem. Biol. 8(2), 376\u2013386 (2013). doi: 10.1021\/cb3003754","journal-title":"ACS Chem. Biol."},{"issue":"2","key":"9473_CR47","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/hyb.1992.11.245","volume":"11","author":"AM Vazquez","year":"1992","unstructured":"Vazquez, A.M., Tormo, B., Velandia, A., Giscombe, R., Ansotegui, I., Jeddi-Tehrani, M., Perez, R., Mellstedt, H., Biberfeld, P.: Characterization of the colorectal antigen IOR-C2. Hybridoma 11(2), 245\u2013256 (1992)","journal-title":"Hybridoma"},{"issue":"4","key":"9473_CR48","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/153685903322328974","volume":"22","author":"L Roque-Navarro","year":"2003","unstructured":"Roque-Navarro, L., Mateo, C., Lombardero, J., Mustelier, G., Fernandez, A., Sosa, K., Morrison, S.L., Perez, R.: Humanization of predicted T-cell epitopes reduces the immunogenicity of chimeric antibodies: new evidence supporting a simple method. Hybrid Hybridomics 22(4), 245\u2013257 (2003). doi: 10.1089\/153685903322328974","journal-title":"Hybrid Hybridomics"},{"issue":"4","key":"9473_CR49","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00262-005-0041-6","volume":"55","author":"J Leon de","year":"2006","unstructured":"de Leon, J., Fernandez, A., Mesa, C., Clavel, M., Fernandez, L.E.: Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cells. Cancer Immunol. Immunother. 55(4), 443\u2013450 (2006). doi: 10.1007\/s00262-005-0041-6","journal-title":"Cancer Immunol. Immunother."},{"issue":"3","key":"9473_CR50","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0006-3002(57)90254-8","volume":"24","author":"L Svennerholm","year":"1957","unstructured":"Svennerholm, L.: Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim. Biophys. Acta 24(3), 604\u2013611 (1957)","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"9473_CR51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193(1), 265\u2013275 (1951)","journal-title":"J. Biol. Chem."},{"issue":"4","key":"9473_CR52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/153685903322328965","volume":"22","author":"A Lopez-Requena","year":"2003","unstructured":"Lopez-Requena, A., Mateo de Acosta, C., Perez, A., Valle, A., Lombardero, J., Sosa, K., Perez, R., Vazquez, A.M.: Chimeric anti-N-glycolyl-ganglioside and its anti-idiotypic MAbs: immunodominance of their variable regions. Hybrid Hybridomics 22(4), 235\u2013243 (2003)","journal-title":"Hybrid Hybridomics"},{"issue":"8","key":"9473_CR53","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1021\/ac035511t","volume":"76","author":"I Meisen","year":"2004","unstructured":"Meisen, I., Peter-Katalinic, J., Muthing, J.: Direct analysis of silica gel extracts from immunostained glycosphingolipids by nanoelectrospray ionization quadrupole time-of-flight mass spectrometry. Anal. Chem. 76(8), 2248\u20132255 (2004). doi: 10.1021\/ac035511t","journal-title":"Anal. Chem."},{"issue":"3","key":"9473_CR54","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1021\/ac0514669","volume":"78","author":"R Lemaire","year":"2006","unstructured":"Lemaire, R., Tabet, J.C., Ducoroy, P., Hendra, J.B., Salzet, M., Fournier, I.: Solid ionic matrixes for direct tissue analysis and MALDI imaging. Anal. Chem. 78(3), 809\u2013819 (2006). doi: 10.1021\/ac0514669","journal-title":"Anal. Chem."},{"issue":"11","key":"9473_CR55","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1021\/ac100818g","volume":"82","author":"M Strohalm","year":"2010","unstructured":"Strohalm, M., Kavan, D., Novak, P., Volny, M., Havlicek, V.: mMass 3: a cross-platform software environment for precise analysis of mass spectrometric data. Anal. Chem. 82(11), 4648\u20134651 (2010). doi: 10.1021\/ac100818g","journal-title":"Anal. Chem."},{"issue":"1 Suppl","key":"9473_CR56","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1111\/j.1365-2567.2009.03052.x","volume":"128","author":"KA Cycon","year":"2009","unstructured":"Cycon, K.A., Clements, J.L., Holtz, R., Fuji, H., Murphy, S.P.: The immunogenicity of L1210 lymphoma clones correlates with their ability to function as antigen-presenting cells. Immunology 128(1 Suppl), e641\u2013e651 (2009). doi: 10.1111\/j.1365-2567.2009.03052.x","journal-title":"Immunology"},{"issue":"1","key":"9473_CR57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1432-1033.1979.tb12866.x","volume":"94","author":"J Portoukalian","year":"1979","unstructured":"Portoukalian, J., Zwingelstein, G., Dore, J.F.: Lipid composition of human malignant melanoma tumors at various levels of malignant growth. Eur. J. Biochem. 94(1), 19\u201323 (1979)","journal-title":"Eur. J. Biochem."},{"issue":"1","key":"9473_CR58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jnci\/78.1.45","volume":"78","author":"T Tsuchida","year":"1987","unstructured":"Tsuchida, T., Saxton, R.E., Morton, D.L., Irie, R.F.: Gangliosides of human melanoma. J. Natl. Cancer. Inst. 78(1), 45\u201354 (1987)","journal-title":"J. Natl. Cancer. Inst."},{"issue":"2","key":"9473_CR59","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bbrc.2006.12.001","volume":"353","author":"MH Ravindranath","year":"2007","unstructured":"Ravindranath, M.H., Muthugounder, S., Presser, N., Selvan, S.R., Santin, A.D., Bellone, S., Saravanan, T.S., Morton, D.L.: Immunogenic gangliosides in human ovarian carcinoma. Biochem. Biophys. Res. Commun. 353(2), 251\u2013258 (2007). doi: 10.1016\/j.bbrc.2006.12.001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"20","key":"9473_CR60","first-page":"5680","volume":"48","author":"T Dohi","year":"1988","unstructured":"Dohi, T., Nores, G., Hakomori, S.: An IgG3 monoclonal antibody established after immunization with GM3 lactone: immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo. Cancer Res. 48(20), 5680\u20135685 (1988)","journal-title":"Cancer Res."},{"issue":"21","key":"9473_CR61","first-page":"5244","volume":"53","author":"DS Hoon","year":"1993","unstructured":"Hoon, D.S., Wang, Y., Sze, L., Kanda, H., Watanabe, T., Morrison, S.L., Morton, D.L., Irie, R.F.: Molecular cloning of a human monoclonal antibody reactive to ganglioside GM3 antigen on human cancers. Cancer Res. 53(21), 5244\u20135250 (1993)","journal-title":"Cancer Res."},{"issue":"2","key":"9473_CR62","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1523-1747.1999.00493.x","volume":"112","author":"T Takahashi","year":"1999","unstructured":"Takahashi, T., Johnson, T.D., Nishinaka, Y., Morton, D.L., Irie, R.F.: IgM anti-ganglioside antibodies induced by melanoma cell vaccine correlate with survival of melanoma patients. J. Invest. Dermatol. 112(2), 205\u2013209 (1999). doi: 10.1046\/j.1523-1747.1999.00493.x","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"9473_CR63","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00262-003-0436-1","volume":"53","author":"RF Irie","year":"2004","unstructured":"Irie, R.F., Ollila, D.W., O\u2019Day, S., Morton, D.L.: Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma. Cancer Immunol. Immunother. 53(2), 110\u2013117 (2004). doi: 10.1007\/s00262-003-0436-1","journal-title":"Cancer Immunol. Immunother."},{"issue":"9","key":"9473_CR64","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.febslet.2009.10.065","volume":"584","author":"SI Hakomori","year":"2010","unstructured":"Hakomori, S.I.: Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility. FEBS Lett. 584(9), 1901\u20131906 (2010). doi: 10.1016\/j.febslet.2009.10.065","journal-title":"FEBS Lett."},{"key":"9473_CR65","author":"K Handa","year":"2012","unstructured":"Handa, K., Hakomori, S.I.: Carbohydrate to carbohydrate interaction in development process and cancer progression. Glycoconj. J. (2012). doi: 10.1007\/s10719-012-9380-7","journal-title":"Glycoconj. J."},{"issue":"13","key":"9473_CR66","first-page":"3850","volume":"62","author":"R Watanabe","year":"2002","unstructured":"Watanabe, R., Ohyama, C., Aoki, H., Takahashi, T., Satoh, M., Saito, S., Hoshi, S., Ishii, A., Saito, M., Arai, Y.: Ganglioside G(M3) overexpression induces apoptosis and reduces malignant potential in murine bladder cancer. Cancer Res. 62(13), 3850\u20133854 (2002)","journal-title":"Cancer Res."},{"issue":"1","key":"9473_CR67","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/glycob\/cwp143","volume":"20","author":"A Prinetti","year":"2010","unstructured":"Prinetti, A., Aureli, M., Illuzzi, G., Prioni, S., Nocco, V., Scandroglio, F., Gagliano, N., Tredici, G., Rodriguez-Menendez, V., Chigorno, V., Sonnino, S.: GM3 synthase overexpression results in reduced cell motility and in caveolin-1 upregulation in human ovarian carcinoma cells. Glycobiology 20(1), 62\u201377 (2010). doi: 10.1093\/glycob\/cwp143","journal-title":"Glycobiology"},{"issue":"47","key":"9473_CR68","doi-asserted-by":"crossref","first-page":"40900","DOI":"10.1074\/jbc.M111.286146","volume":"286","author":"A Prinetti","year":"2011","unstructured":"Prinetti, A., Cao, T., Illuzzi, G., Prioni, S., Aureli, M., Gagliano, N., Tredici, G., Rodriguez-Menendez, V., Chigorno, V., Sonnino, S.: A glycosphingolipid\/caveolin-1 signaling complex inhibits motility of human ovarian carcinoma cells. J. Biol. Chem. 286(47), 40900\u201340910 (2011). doi: 10.1074\/jbc.M111.286146","journal-title":"J. Biol. Chem."},{"issue":"2","key":"9473_CR69","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0361-090X(02)00033-8","volume":"26","author":"H Nojiri","year":"2002","unstructured":"Nojiri, H., Yamana, H., Shirouzu, G., Suzuki, T., Isono, H.: Glycotherapy for cancer: remodeling of ganglioside pattern as an effective approach for cancer therapy. Cancer Detect. Prev. 26(2), 114\u2013120 (2002)","journal-title":"Cancer Detect. Prev."},{"issue":"1","key":"9473_CR70","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/cdd.2008.141","volume":"16","author":"C Tringali","year":"2009","unstructured":"Tringali, C., Lupo, B., Cirillo, F., Papini, N., Anastasia, L., Lamorte, G., Colombi, P., Bresciani, R., Monti, E., Tettamanti, G., Venerando, B.: Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3. Cell Death Differ. 16(1), 164\u2013174 (2009). doi: 10.1038\/cdd.2008.141","journal-title":"Cell Death Differ."},{"issue":"1","key":"9473_CR71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbamem.2008.09.001","volume":"1788","author":"A Prinetti","year":"2009","unstructured":"Prinetti, A., Loberto, N., Chigorno, V., Sonnino, S.: Glycosphingolipid behaviour in complex membranes. Biochim. Biophys. Acta 1788(1), 184\u2013193 (2009). doi: 10.1016\/j.bbamem.2008.09.001","journal-title":"Biochim. Biophys. Acta"},{"key":"9473_CR72","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1756-9966-28-146","volume":"28","author":"MR Gabri","year":"2009","unstructured":"Gabri, M.R., Otero, L.L., Gomez, D.E., Alonso, D.F.: Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines. J. Exp. Clin. Cancer Res. 28, 146 (2009). doi: 10.1186\/1756-9966-28-146","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"9473_CR73","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fonc.2012.00160","volume":"2","author":"VI Segatori","year":"2012","unstructured":"Segatori, V.I., Vazquez, A.M., Gomez, D.E., Gabri, M.R., Alonso, D.F.: Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer. Front. Oncol. 2, 160 (2012). doi: 10.3389\/fonc.2012.00160","journal-title":"Front. Oncol."},{"issue":"4","key":"9473_CR74","first-page":"609","volume":"26","author":"VI Segatori","year":"2012","unstructured":"Segatori, V.I., Otero, L.L., Fernandez, L.E., Gomez, D.E., Alonso, D.F., Gabri, M.R.: Antitumor protection by NGcGM3\/VSSP vaccine against transfected B16 mouse melanoma cells overexpressing N-glycolylated gangliosides. In Vivo 26(4), 609\u2013617 (2012)","journal-title":"In Vivo"},{"issue":"2","key":"9473_CR75","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1517\/14712590903443084","volume":"10","author":"M Labrada","year":"2010","unstructured":"Labrada, M., Clavell, M., Bebelagua, Y., Leon, J., Alonso, D.F., Gabri, M.R., Veloso, R.C., Verez, V., Fernandez, L.E.: Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy. Expert. Opin. Biol. Ther. 10(2), 153\u2013162 (2010). doi: 10.1517\/14712590903443084","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"46","key":"9473_CR76","doi-asserted-by":"crossref","first-page":"16204","DOI":"10.1073\/pnas.0407297101","volume":"101","author":"Y Miura","year":"2004","unstructured":"Miura, Y., Kainuma, M., Jiang, H., Velasco, H., Vogt, P.K., Hakomori, S.: Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside). Proc. Natl. Acad. Sci. U. S. A. 101(46), 16204\u201316209 (2004). doi: 10.1073\/pnas.0407297101","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"22","key":"9473_CR77","doi-asserted-by":"crossref","first-page":"8662","DOI":"10.1158\/0008-5472.CAN-09-1099","volume":"69","author":"JW Liu","year":"2009","unstructured":"Liu, J.W., Sun, P., Yan, Q., Paller, A.S., Gerami, P., Ho, N., Vashi, N., Le Poole, I.C., Wang, X.Q.: De-N-acetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activation. Cancer Res. 69(22), 8662\u20138669 (2009). doi: 10.1158\/0008-5472.CAN-09-1099","journal-title":"Cancer Res."},{"issue":"5","key":"9473_CR78","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D., Weinberg, R.A.: Hallmarks of cancer: the next generation. Cell 144(5), 646\u2013674 (2011). doi: 10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"issue":"3\u20134","key":"9473_CR79","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0300-9084(03)00006-3","volume":"85","author":"S Birkle","year":"2003","unstructured":"Birkle, S., Zeng, G., Gao, L., Yu, R.K., Aubry, J.: Role of tumor-associated gangliosides in cancer progression. Biochimie 85(3\u20134), 455\u2013463 (2003)","journal-title":"Biochimie"},{"key":"9473_CR80","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-0-387-72005-0_20","volume":"601","author":"M Potapenko","year":"2007","unstructured":"Potapenko, M., Shurin, G.V., de Leon, J.: Gangliosides as immunomodulators. Adv. Exp. Med. Biol. 601, 195\u2013203 (2007)","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"9473_CR81","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/intimm\/dxn018","volume":"20","author":"J Leon de","year":"2008","unstructured":"de Leon, J., Fernandez, A., Clavell, M., Labrada, M., Bebelagua, Y., Mesa, C., Fernandez, L.E.: Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4\u2009+\u2009CD25- effector and naturally occurring CD4\u2009+\u2009CD25+ regulatory T cells function. Int. Immunol. 20(4), 591\u2013600 (2008). doi: 10.1093\/intimm\/dxn018","journal-title":"Int. Immunol."},{"issue":"2","key":"9473_CR82","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-3083.1995.tb03547.x","volume":"41","author":"M Sorice","year":"1995","unstructured":"Sorice, M., Pavan, A., Misasi, R., Sansolini, T., Garofalo, T., Lenti, L., Pontieri, G.M., Frati, L., Torrisi, M.R.: Monosialoganglioside GM3 induces CD4 internalization in human peripheral blood T lymphocytes. Scand. J. Immunol. 41(2), 148\u2013156 (1995)","journal-title":"Scand. J. Immunol."},{"issue":"52","key":"9473_CR83","doi-asserted-by":"crossref","first-page":"35153","DOI":"10.1074\/jbc.273.52.35153","volume":"273","author":"T Garofalo","year":"1998","unstructured":"Garofalo, T., Sorice, M., Misasi, R., Cinque, B., Giammatteo, M., Pontieri, G.M., Cifone, M.G., Pavan, A.: A novel mechanism of CD4 down-modulation induced by monosialoganglioside GM3. Involvement of serine phosphorylation and protein kinase c delta translocation. J. Biol. Chem. 273(52), 35153\u201335160 (1998)","journal-title":"J. Biol. Chem."},{"issue":"1","key":"9473_CR84","first-page":"363","volume":"61","author":"GV Shurin","year":"2001","unstructured":"Shurin, G.V., Shurin, M.R., Bykovskaia, S., Shogan, J., Lotze, M.T., Barksdale Jr., E.M.: Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. Cancer Res. 61(1), 363\u2013369 (2001)","journal-title":"Cancer Res."},{"issue":"7","key":"9473_CR85","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.4049\/jimmunol.170.7.3488","volume":"170","author":"J Peguet-Navarro","year":"2003","unstructured":"Peguet-Navarro, J., Sportouch, M., Popa, I., Berthier, O., Schmitt, D., Portoukalian, J.: Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis. J. Immunol. 170(7), 3488\u20133494 (2003)","journal-title":"J. Immunol."},{"issue":"10","key":"9473_CR86","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/glycob\/cwn072","volume":"18","author":"V Padler-Karavani","year":"2008","unstructured":"Padler-Karavani, V., Yu, H., Cao, H., Chokhawala, H., Karp, F., Varki, N., Chen, X., Varki, A.: Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease. Glycobiology 18(10), 818\u2013830 (2008). doi: 10.1093\/glycob\/cwn072","journal-title":"Glycobiology"},{"issue":"8","key":"9473_CR87","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.20100575","volume":"207","author":"RE Taylor","year":"2010","unstructured":"Taylor, R.E., Gregg, C.J., Padler-Karavani, V., Ghaderi, D., Yu, H., Huang, S., Sorensen, R.U., Chen, X., Inostroza, J., Nizet, V., Varki, A.: Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid. J. Exp. Med. 207(8), 1637\u20131646 (2010). doi: 10.1084\/jem.20100575","journal-title":"J. Exp. Med."},{"issue":"48","key":"9473_CR88","doi-asserted-by":"crossref","first-page":"18936","DOI":"10.1073\/pnas.0803943105","volume":"105","author":"M Hedlund","year":"2008","unstructured":"Hedlund, M., Padler-Karavani, V., Varki, N.M., Varki, A.: Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression. Proc. Natl. Acad. Sci. U. S. A. 105(48), 18936\u201318941 (2008). doi: 10.1073\/pnas.0803943105","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"9473_CR89","first-page":"5541","volume":"46","author":"H Fuji","year":"1986","unstructured":"Fuji, H., Iribe, H.: Clonal variation in tumorigenicity of L1210 lymphoma cells: nontumorigenic variants with an enhanced expression of tumor-associated antigen and Ia antigens. Cancer Res. 46(11), 5541\u20135547 (1986)","journal-title":"Cancer Res."}],"container-title":["Glycoconjugate Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-013-9473-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10719-013-9473-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-013-9473-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T19:21:30Z","timestamp":1644693690000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10719-013-9473-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,2]]},"references-count":89,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["9473"],"URL":"https:\/\/doi.org\/10.1007\/s10719-013-9473-y","relation":{},"ISSN":["0282-0080","1573-4986"],"issn-type":[{"value":"0282-0080","type":"print"},{"value":"1573-4986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,2]]}}}